photobacterium Vibrio fischeri, QS is a mechanism by Buffalo, New York 14260 which bacterial communities can communicate to rapidly alter gene expression based on cell population density [12]. Small amounts of a secreted signaling compound called an autoinducer (AI) accumulate with Summary increasing population density (reviewed in [13]). These compounds pass between cells and, when present at We synthesized a library of Pseudomonas aeruginosa concentrations representative of a "quorum," bind a regautoinducer analogs with variation targeted to the houlatory protein, thereby activating it as a transcription moserine lactone (HSL) moiety and discovered a new factor. The regulatory protein is a member of the LuxR agonist, 3-oxo-C 12 -(2-aminocyclohexanol), capable of family of transcription factors, and targets for transcripactivating LasR as a transcription factor. We recontional activation include genes encoding the LuxR prostructed two sets of focused libraries against the quotein and the autoinducer synthase, a LuxI homolog. This rum-sensing transcription factors LasR and RhlR, recreates a positive feedback, autoinducing loop. spectively. Opposing the prediction that both proteins
screening of random analog libraries is the only available method to discover antagonists.
Previous work to isolate autoinducer antagonists focused on altering the side chain [26, 30] . These attempts provided evidence that the length of the side chain can be altered somewhat with little effect on activity, but drastic changes of length or substitution with bulky groups proximal to the HSL group eliminates activity. No potent antagonists were discovered from these studies. Since HSL is the common structural element in all AIs 
and tested for biological activity. Among these, only substitution of HSL with homocysteine lactone exhibited
To explore further the requirements for LasR binding a comparable activity to P. aeruginosa AI1 [30] . Clearly and activation, we chose to focus on the most active much work needs to be done before we have sufficient compound, 3-oxo-C 12 -(2-aminocyclohexanol) (Figure 1 , knowledge of the R protein-HSL interaction to design 4), which was able to induce GFP at concentrations effective QS inhibitors.
comparable to the natural AI1 (Figures 2A and 2B, 4) . Very recently, progress has been made on the path Superimposition of the amino and hydroxyl groups in to elucidate the structure of R proteins. The crystal this molecule with the amino and keto groups in HSL structure of TraR, the LuxR homolog from Agrobactersuggests similarities in structure. This led us to hypotheium tumefaciens, complexed with its AI and DNA, was size that a 5-or 6-membered ring with a keto or hydroxl published [31] . The crystal shows the HSL ring keto group (or other hydrogen bond acceptor) adjacent to group in a hydrogen bond with Trp57. This residue as the amine is sufficient for both binding and activation well as Asp70 and Tyr53, which interact with the amide of LasR. To test this hypothesis, we synthesized the group of the acyl-HSL linkage, are conserved in both series of molecules shown in Figure 1 (compounds 1-3 ). LasR and RhlR. However, the AI binding site is not com-We were also interested in whether analogs binding to pletely conserved between the published structure of one R protein could bind other R proteins simply by TraR and either LasR or RhlR, and neither LasR nor RhlR substituting the cognate side chain. We therefore synis strongly activated by the A. tumefaciens AI, 3-oxothesized a second series of molecules (Figure 1 , 5-8) C 8 -HSL [30] . The variability in AI structure conferring R with C 4 side chains and tested their ability to activate protein specificity is limited to the length and substitu-RhlR using an rhlI-gfp reporter strain, PAO-JP2 (prhlItions of the acyl side chain [11] . Does this suggest that LVAgfp) [32] . all R proteins bind the HSL moiety in a similar manner? Can we modify the HSL structure in such a way as to Results and Discussion create a general antagonist that can be applied to all R proteins simply by substituting the appropriate acyl Reporter Gene Assays chain? The answer to these questions will aid in the Using the PAO-JP2 (plasI-LVAgfp) reporter strain, we rational design of analogs that can bind and inhibit R first tested activity of the 3-oxo-C 12 molecules, AI1 and proteins in organisms such as P. aeruginosa and others 1-4. Strong QS induction by AI1 was evidenced by the of medical and economic importance that use QS to high GFP signal observed at as low as 1 M of AI1 regulate essential life processes. (Figures 2A and 2B, AI1 ). Our previously identified ago-To explore the above questions, we synthesized a nist, 3-oxo-C 12 -(2-aminocyclohexanol) 4, showed strong library of AI1 analogs in which the 3-oxo-C 12 side chain agonist activity with GFP induction only 2-fold less than was retained and the HSL group was altered to various AI1 at 1 M and comparable to AI1 at higher concentraamines and alcohols (a total of 96 molecules were syntions (Figures 2A and 2B, 4) . 3-oxo-C 12 -(2-aminocyclothesized) (Y.B., K.M.S., and H.S., unpublished data). To pentanone) 1 is structurally more similar to AI1 than 4, screen our library for biological activity, we used a P. since the oxygen of HSL was simply replaced with caraeruginosa strain in which both AI synthase genes had bon in 1. Hence, we expected that 1 would have strong been knocked out (PAO-JP2, lasI, rhlI) [14] harboring agonist activity. Contrary to this prediction, 1 was able plasmid plasI-LVAgfp [32] . When grown in the presence to induce the reporter only at a very high concentration of exogenously added AI1, the LasR-AI1 complex acti- (Figures 2A and 2B, 1) . Even more surprising, comvates transcription of the lasI promoter that controls pounds 2 and 3 were nearly unable to induce the regfp expression. This provides a simple, high-throughput porter, even at high concentrations (Figures 2A and 2B , method to detect the activity of analogs by measuring 2 and 3). and agonist assays, therefore, were performed in the 1 is a weak agonist, and 2-aminocyclohexanone 3 has no agonist activity. Thus, based on our results, we pro-presence of 1 M AI1 and increasing concentrations of AI2 or analog ( Figures 2C and 2D ). Both ketone deriva-pose that the microenvironment of the protein-HSL interface differs between LasR, RhlR, and TraR. tives, 5 and 7, showed strong agonist activity, inducing the reporter at just 10 M ( Figures 2C and 2D, 5 and 7) .
The most intriguing observation is that a subtle structural change from hydroxyl to keto group on the cyclo-In contrast, the 2-aminocyclopentanol derivative 6 had no agonist activity. Moreover, the 2-aminocyclohexanol hexane ring (4 → 3), or from keto to hydroxyl group on the cyclopentane ring (1 → 2 or 5 → 6), drastically reduced derivative 8 had very little AI2 agonist activity; it could induce only moderate GFP expression at 400 M (Fig-agonist activity. It is unlikely that such a small structural difference would completely eliminate binding to the ures 2C and 2D, column 8).
As mentioned above, we initially assumed that since respective R protein. A more likely, alternative explanation is that the cyclopentanol (2) and cyclohexanone (3) 2-aminocyclopentanone (1 and 5) and 2-aminocyclohexanone (3 and 7) have a keto group, they would better compounds can still bind LasR with similar affinity but are unable to activate it. Therefore, we speculated that mimic the HSL structure than 2-aminocyclopentanol (2 and 6) and 2-aminocyclohexanol (4 and 8). In fact, in compounds 2 and 3 might act as AI1 antagonists. Similarly, compound 6 should maintain the ability to bind the rhl circuit, the ketone derivates are better agonists of AI2 than the alcohol derivatives. This is also consis-RhlR and therefore might act as an AI2 antagonist. tent with the crystal structure of the TraR-3-oxo-C 8 HSL complex, which shows the ketone participating in an H Antagonist Assays Based on the above hypothesis, we performed a compe-bond. Presumably, an alcohol substitution could maintain the H bond, but less efficient binding would be tition assay of 2 and 3 against AI1, using strain PAO-JP2 (plasI-LVAgfp). As predicted, compound 2 inhibited expected. The results for the AI1 analogs, however, do not fit this pattern. In the las circuit, 2-aminocyclohexa-GFP expression approximately 70% at a 100-fold excess concentration over AI1 ( Figure 3A) , and compound 3 nol 4 is the strongest agonist, 2-aminocyclopentanone ing results were obtained from the assay of compound 3, where GFP expression of the rhlI-gfp reporter was inhibited by greater than 60% at 50 M when competing against 1 M AI1 and 10 M AI2 ( Figure 3B ).
Inhibition by compound 3 of the rhlI-gfp reporter was greater than that seen with the lasI-gfp reporter. Results from the lasI-gfp assay suggest that 3 inhibits LasR-AI1-dependent activation of transcription ( Figure 3A ). Since the rhlR promoter is also activated by LasR-AI1, inhibition of rhlI-gfp in the presence of 3 is likely due to inhibition of LasR-AI1-dependent activation of rhlR expression. This then translates into reduced activation of RhlR-AI2-dependent rhlI-gfp expression. It is also possible, however, that 3 directly interacts with RhlR and prevents AI2 binding, since AI1 is able to act as an antagonist against RhlR and prevent binding by AI2 [18] . The AI2 analog with the same ring structure as compound 3 (compound 7, 2-aminocyclohexanone) is a strong agonist of RhlR. This supports the speculation that 3 could enter the AI binding site of RhlR and antagonize the RhlR-AI2 interaction. The chain length of RhlR autoinducers appears to be the determining factor regulating RhlR activation, since C 4 HSL activates RhlR but way than lasI, we would expect to see stronger inhibition of rhlI than lasI.
had a lesser inhibitory effect (35% reduction) under the same conditions. It should be noted that this inhibition
Virulence Factor Assays In order to provide further evidence that compounds 2 experiment was performed with competition against 1 M AI1, a concentration typically produced by wild-and 3 are disrupting QS, we tested their ability to reduce expression of virulence factors in both the AI synthase type P. aeruginosa [17]. These results suggest that both molecules bind LasR and prevent it from being activated knockout (PAO-JP2) and wild-type (PAO1) P. aeruginosa strains. We chose to assay two important virulence fac-by AI1. This view is supported by the compounds' inability to inhibit GFP expression when the lasI promoter is tors in Pseudomonas infections: first, the pigment pyocyanin that is required for disease in the Arabidopsis replaced with a lac promoter in strain PAO-JP2 (pTdK-GFP) [32] (data not shown). It should also be noted that thaliana [34] , Caenorhabditis elegans [4] , and Galleria mellonella [35] infection models and causes serious tis-cell growth was not affected by the addition of 2 or 3 at concentrations up to 400 M (data not shown). Thus, sue damage in chronic lung infections [36] ; second, the metalloprotease elastase B, which degrades immune it appears that compounds 2 and 3 act as specific inhibitors of QS-controlled promoters. Compound 6 was also components and causes tissue damage [37] .
Strong induction of pyocyanin in P. aeruginosa PAO-tested for its ability to compete against AI2, but no inhibition of the rhlI-gfp reporter gene was seen (data not JP2 requires addition of both AI1 and AI2 (Figures 4A and 4B). When compound 3 was added in combination shown).
Next, we tested the ability of 2 and 3 to inhibit the with exogenous AIs, there was nearly complete inhibition of pyocyanin expression ( Figures 4A and 4B) . A very rhlI-gfp reporter strain PAO-JP2 (prhlI-LVAgfp), since this expression is also AI1 dependent. The Iglewski similar inhibitory effect by 3 was observed when wildtype P. aeruginosa (PAO1) was assayed ( Figure 4C) . The group recently reported that the rhlI promoter is induced primarily by the LasR-AI1 complex [19] , but we see no concentration-dependent inhibitory effect of 3 leads us to believe that 3 is specifically competing against AI induction of this promoter with the addition of only AI1 (data not shown). It is possible that the rhlI-lacZ reporter activation of pyocyanin expression. Compound 2, on the other hand, reduced pyocyanin expression by 50% used in their study is more sensitive than the rhlI-gfp construct used in our study, and the small amount of in PAO-JP2 ( Figures 4A and 4B ), but the inhibition was not concentration dependent over the range tested. GFP induced by AI1 is below our limit of detection. However, since both AI1 and AI2 are required to induce Moreover, 2 had no significant effect on PAO1 ( Figure  4C) . We therefore think that the inhibitory effect of 2 on GFP from the PAO-JP2 (prhlI-LVAgfp) reporter, we interpret our data in the context of earlier experiments that pyocyanin expression is not as significant as that of 3. For the elastase B assay, a colorimetric assay was showed predominantly RhlR-AI2 activation of the rhlI promoter [33] . Surprisingly, compound 2 showed no an-conducted using elastin congo red substrate, so the observed protease activity is predominantly due to elas-tagonist activity in this assay ( Figure 3B ). More promis- 4D and 4E) [38] . Our control experiment showed that 5 M AI1 and 10 M visualization by scanning confocal laser microscopy. The PAO-JP2 autoinducer synthase knockout strain did AI2 were required for consistent induction of elastase B activity in PAO-JP2. At 50 M 3, elastase activity was not form a biofilm unless AIs were added ( Figure 5A ). When this strain was grown in the presence of AIs plus reduced to 60% of the positive control level ( Figure 4D ). When the same assay was performed on wild-type P.
tase B and not other proteases that might be present biofilm formation [32]. Strain PAO-JP2 (pTdK-GFP) [32] contains a constitutively expressed GFP construct for in culture supernatants (Figures
3, biofilm formation was completely inhibited (Figure 5A , right panel). Inhibition of biofilm formation in the wild-aeruginosa, elastase activity was reduced to 30% of the control level in the presence of 100 M 3 ( Figure 4E ). type strain PAO1 (pTdK-GFP) ( Figure 5B ) was less obvious, but there was a noticeable difference in biofilm These results indicate that 3 likely inhibits elastase B expression, although the inhibition was not as strong morphology when grown in the presence of 3. The above results provide additional evidence that compound 3 as that observed for pyocyanin expression. On the other hand, compound 2 had no significant effect on elastase interferes with QS signaling and reduces the production of important virulence factors. activity produced by either strain (Figures 4D and 4E) . Since 2 showed weaker inhibition of pyocyanin and elastase production than 3, future studies focused solely Conclusions and Outlook on 3.
The initial screen of our library yielded a potent agonist of AI1, and we elaborated this compound further to support our hypothesis that the HSL ring could be agonized Static Biofilm Assay There is evidence that the chronic nature of P. aerugi-by a 5-or 6-membered ring system with a hydrogen bond acceptor at position 1 (hydroxyl or oxo group).
nosa infections is due in part to biofilm growth [39, 40]. Biofilm is an attached colony of bacteria protected from We targeted both the las and rhl systems in this study, synthesizing the same compounds with either a 3-oxo-biocide treatment and the host immune response by a secreted polysaccharide matrix [41]. Its development in C 12 side chain or a C 4 side chain. The results of the study of agonist activity of the analogs were unexpected. We P. aeruginosa is QS controlled, and disruption of QS has been shown to eliminate or reduce biofilm develop-found that the requirements for binding of AI differ between the homologs LasR and RhlR. LasR was activated ment [22, 25, 42]. Prevention of biofilm growth continues to be a challenge, since treatment of biofilm colonies best by 3-oxo-C 12 -(2-aminocyclohexanol), and RhlR was activated equally well by C 4 -(2-aminocyclopentanone) has proven extremely difficult.
We tested compound 3 for its effect on biofilm devel-and C 4 -(2-aminocyclohexanone). Our results suggest that even though all I proteins synthesize an acylated opment in a 24 hr assay that looks at the early stages of biofilm formation. The static biofilm assay is a simple HSL, the R proteins do not necessarily recognize the HSL moiety in the same manner. Further elaboration of yet reliable method to monitor QS-controlled steps of the structure of these synthetic agonists may provide agonize the las cascade. Future studies will focus on discovery of a specific AI2 antagonist that could be new insights into the specificity of the R protein-AI interaction.
used in combination with our AI1 antagonist or a single compound capable of inhibiting both LasR and RhlR. It While attempting to elucidate structural elements required for agonist activity, we found compounds with is necessary to discover such antagonists since both cascades need to be eliminated for effective QS inhibi-antagonist activity. Compound 2, 3-oxo-C 12 -(2-aminocyclopentanol), inhibited the lasI-gfp reporter very effec-tion, as there is evidence that the rhl cascade can become activated in the absence of the las cascade under tively but had no effect on the rhlI-gfp reporter and was only mildly effective at disrupting QS-regulated viru-certain selective conditions [43]. The most active P. aeruginosa AI1 antagonist pre-lence factor expression. Why did compound 2 fail to exhibit inhibitory action in the rhlI-gfp reporter and viru-viously identified, recently reported by Hentzer et al. [27] , is derived from the halogenated furanones of Delissea lence factor assays? Our current hypothesis relates to the issue raised in the discussion that 3 may directly pulchra. This compound displays similar properties to our compound 3 in that it inhibits QS at roughly 100-bind RhlR and prevent AI2 binding. Compound 2 may be unable to interact with RhlR, so its QS inhibitory fold excess concentrations over the natural AIs. It is difficult to make direct comparisons of the activity of activity is mediated purely through disruption of the LasR-AI1 interaction. This speculation is supported by these compounds, however, since different promoters were used to control the reporter systems that deter-the fact that the AI2 analog with the same ring structure as 2 (compound 6, 2-aminocyclopentanol) (3 and 7) . These questions require further study.
include the lasI promoter used in our reporter assay, are induced early after a quorum is reached and respond Compound 3, 3-oxo-C 12 -(2-aminocyclohexanone), inhibited both the lasI and rhlI reporters, pyocyanin, elas-strongly to only AI1. The lasB promoter used in the Hentzer study is a class IV promoter that requires both tase, and biofilm. While 3 appears to inhibit the rhl cascade somewhat, it was disappointing that none of the AI1 and AI2 for full induction and responds very little to AI1 alone. Perhaps this is not relevant when inhibition AI2 analogs showed antagonist activity toward the rhl cascade. AI1 has weak antagonist activity toward RhlR assays are performed in heterologous systems lacking other regulators of QS-controlled genes, but we should [18] , as might 3, following the general trend that long chain AIs antagonize R proteins that are activated by cautiously consider this when comparing data collected in P. aeruginosa. We think our system using a class I short chain AIs [26] . We currently lack a potent antagonist for the rhl cascade, particularly one that does not promoter is more difficult to inhibit, so our antagonist 95, 29.20, 29.30, 29.35, 30.3, 31.8, 32.6, 44.0, 47.9, 60.7, 79 our studies were much higher than those typically used (m, 12H), 1.52 (m, 2H), 1.62 (m, 1H), 1.78-1.96 (m, 3H) 6, 28.9, 29.24, 29.29, 29.42, 30.66, 30.69, 31.8, 36.6, 57.3, 87 (35 mg, 0.256 mmol, pur-(m, 12H), 1.52-1.64 (m, 2H), 1.64-1.76 (m, 1H), 1.80-1.92 (m, 1H) , chased from Aldrich, 52,586-3) in anhydrous DMF (2 ml) was added 2.04- 2.16 (m, 1H), 1.98-2.08 (m, 1H), 2.36-2.44 (m, 1H) N-(trans-2-hydroxycyclopentyl)-3-oxododecanamide in the ketone  23.3, 24.0, 27.9, 28.96, 29.20, 29.31, 29.34, 31.8, 35.1, 41.1, 43.7,  form (14.8 mg, 0.050 mmol, R f ϭ 0.42) and the enol form (19.2 mg,  49.2, 58.2, 165.3, 206.0 0.88 (t, J ϭ 7 Hz, 3H), 1.20-1.35 (m, 12H), 1.48-1.52 (m, 1H), 1.58  2-hydroxy)cyclohexylbutanamide (8)  (m, 2H), 1.60-1.78 (m, 2H), 1.81 (m, 1H), 2.05 (m, 1H), 2.16 (m, 1H) ,
The procedure for the preparation of C 4 -HSL was used for this series of molecules. The EDC-mediated coupling of butyric acid and trans-2.52 (t, J ϭ 7 Hz, 2H), 3.42 (s, 2H), 3.84 (m, 1H), 3.98 (m, 1H), 4.24 
